PersonnelStraumann Group announces Executive Management Board changes 26.02.2025 / 07:00 CET/CESTBasel, February 26, 2025: Today the Straumann Group announces two executive management board changes.

Annual ResultsGerresheimer delivers solid results in the financial year 2024 despite market headwinds 26.02.2025 / 07:00 CET/CESTThe issuer is solely responsible for the content of this ...

Retinal Biologics MarketThe Retinal Biologics Market generated USD 19.96 billion in revenue in 2021 and is projected to grow ...

The global Psoriatic Arthritis (PsA) Treatment Market is expected to grow from USD 11,973.7 million in 2024 to USD 25,375.6 ...

Endometriosis Treatment MarketThe global Endometriosis Treatment Market is projected to grow from USD 3,727.4 million in 2025 ...

Radiation-Induced Myelosuppression Treatment MarketThe global Radiation-Induced Myelosuppression Treatment Market is ...

IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the ...

Market OverviewThe Global Monoclonal Antibodies Market has experienced significant growth over the past few decades, driven ...

For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...

A new study into the online conversations of healthcare professionals discussing prostate cancer has revealed a strong focus on emerging therapies, the latest clinical trials, AI-driven diagnostics ...

Ottimo Pharma (“Ottimo”), an innovative biotech company developing one-of-a-kind PD1/VEGFR2 dual pathway antibodies to extend the lives of patients living with cancer, today announces the appointment ...

Antimicrobial Susceptibility Testing MarketThe global Antimicrobial Susceptibility Testing (AST) Market is projected to grow from USD 3.4 billion in 2025 to USD 4.8 billion by 2035, expanding at a ...